Victory Capital Management
VCNX

Victory Capital Management’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Victory Capital Management’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10
Closed -$8K – 3375
2020
Q1 		$8K Buy
+10
New +$11.3K ﹤0.01% 3167
2019
Q4 		– Sell
-2
Closed -$3K – 3365
2019
Q3 		$3K Buy
+2
New +$2.25K ﹤0.01% 3586

Other funds holding VCNX

MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Victory Capital Management's VCNX Position: Q2 2020 in Review

Victory Capital Management sold out of Vaccinex, Inc. Common Stock (VCNX) in Q2 2020, closing a stake of 10 shares — an estimated $8K sold.

Victory Capital Management first reported a position in VCNX in Q3 2019 and held it in 2 quarters. The position peaked at $8K in Q1 2020. 12 funds tracked by Wall St. Rank hold VCNX as of Q2 2020.

  • Victory Capital Management reported no remaining Vaccinex, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 10 Vaccinex, Inc. Common Stock shares in Q2 2020, an estimated $8K.
  • Victory Capital Management first reported a position in Vaccinex, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Vaccinex, Inc. Common Stock position peaked at $8K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.